Sonoma Pharmaceuticals, Inc. (SNOA) Tops Q3 EPS by 13c

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q3 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $3.14 million versus the consensus estimate of $3.76 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters